Wednesday, 4 November 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Latest announcements

Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.

14:36 IST NSE
Other AnnouncementN R Vandana Tex Industries Ltd NRVANDANA

N R Vandana Tex Industries Other Announcement

N R Vandana Tex Industries Limited filed a compliance certificate for the quarter ended March 31, 2026. The Company Secretary confirmed that a Structured Digital Database is in place as per SEBI Insider Trading Regulations. No non-compliance was observed during the financial year, ensuring adherence to regulatory data maintenance standards.

14:32 IST NSE
Board Meeting OutcomeAffordable Robotic & Automation Ltd AFFORDABLE

Affordable Robotic & Automation Board Meeting Outcome

Affordable Robotic & Automation Limited approved a ₹48 Crore fundraise for its subsidiary ARAPL Raas, which will become an associate company as parent shareholding dilutes to 42.50%. The Board also approved ₹150 Crore in related party transactions for FY 2026-27, including a ₹50 Crore promoter loan and ₹100 Crore operational support.

Value
₹198.0 Cr
Execution
Year 2026-27
14:27 IST NSE
New Order WinPower Mech Projects Ltd POWERMECH

Power Mech Projects Bags ₹227.9 Cr Order

Power Mech Projects Limited secured a ₹227.95 Crore order from South Western Railway, Bangalore. The project involves developing a Vande Bharat Sleeper Trains Maintenance Depot in Karnataka on an EPC basis. The contract is to be executed within 30 months, enhancing the company's railway infrastructure portfolio.

Value
₹227.9 Cr
Execution
within 30 months from the Appointed Date
14:26 IST BSE
Board Meeting OutcomeAffordable Robotic & Automation Ltd AFFORDABLE

Affordable Robotic & Automation Board Meeting Outcome

Affordable Robotic & Automation Ltd approved a ₹48 Crore fund raise for its subsidiary, ARAPL Raas, which will become an associate company. The board also approved ₹50 Crore in promoter loans and ₹100 Crore in related party transactions for FY 2026-27. These measures aim to support working capital and the subsidiary's growth.

Value
₹198.0 Cr
Execution
FY 2026-27
14:14 IST NSE
Management ChangeSunlite Recycling Industries Ltd SUNLITE

Sunlite Recycling Industries Management Change

Sunlite Recycling Industries Limited has appointed M/s. RAVI PATEL & CO., Chartered Accountants, as Internal Auditor for the financial year 2026-27. The appointment was approved during the Board Meeting held on April 27, 2026, ensuring compliance with the Companies Act, 2013 and SEBI Listing Regulations.

Execution
Financial Year 2026-27
14:12 IST BSE
Financial ResultsKirloskar Pneumatic Company Ltd KIRLPNU

Kirloskar Pneumatic Company Q4 FY26 Results: Net Profit ₹143.7 Cr, Up 79.4% YoY

Kirloskar Pneumatic Company Ltd reported revenue from operations of ₹711.8 Cr (+20.3% YoY) and net profit of ₹143.7 Cr (+79.4% YoY) for Q4 FY26.

Key figure
Net profit ₹143.7 Cr · +79.4% YoY
14:11 IST BSE
Financial ResultsKirloskar Pneumatic Company Ltd KIRLPNU

Kirloskar Pneumatic Company Financial Results

Kirloskar Pneumatic Company Ltd reported FY2026 financial results and recommended a 425% final dividend (Rs. 8.50/share). It will acquire the remaining 44.74% stake in subsidiary Systems & Components (India) for ₹12.55 Crore, making it wholly owned. The board also approved a 1:2 stock split and appointed new leadership personnel.

Value
₹12.55 Cr
Execution
30 days
14:04 IST NSE
Financial ResultsSunlite Recycling Industries Ltd SUNLITE

Sunlite Recycling Industries H2 FY26 Results: Net Profit ₹26.7 Cr, Up 270.8% YoY

Sunlite Recycling Industries Ltd reported revenue from operations of ₹1,669 Cr (+119.6% YoY) and net profit of ₹26.7 Cr (+270.8% YoY) for H2 FY26.

Key figure
Net profit ₹26.7 Cr · +270.8% YoY
14:02 IST NSE
Financial ResultsSunlite Recycling Industries Ltd SUNLITE

Sunlite Recycling Industries Financial Results

Sunlite Recycling Industries Limited reported audited financial results for FY26, with standalone annual revenue of ₹2,764.72 Crore and PAT of ₹40.15 Crore. The board recommended a final dividend of 10% (₹1 per share). Additionally, the company appointed internal and cost auditors and approved appointments of several directors.

14:01 IST BSE
Other AnnouncementInfonative Solutions Ltd 544393

Infonative Solutions Other Announcement

Infonative Solutions Ltd reported zero investor complaints for the quarter ended March 31, 2026. According to the filing and its Share Transfer Agent, KFIN Technologies, no grievances were pending, received, or unresolved during this period. This routine regulatory disclosure confirms maintaining high standards of investor relations and compliance.

13:55 IST BSE
New Order WinRudra Gas Enterprise Ltd 544121

Rudra Gas Enterprise Bags ₹1.25 Cr Order

Rudra Gas Enterprise Ltd secured a long-term contract from Gujarat Gas and GAIL (India) for Compressed Bio Gas supply. The agreement features an estimated monthly billing of ₹1.25 Crore and remains valid until December 2047. This strategic transaction involves supply via carriers, pipeline networks, and compression arrangements.

Value
₹1.25 Cr
Execution
Up to 31.12.2047
13:55 IST NSE
Management ChangeAye Finance Ltd AYE

Aye Finance Management Change

Aye Finance Limited appointed Mr. Gaurav Seth as Chief Financial Officer, succeeding Mr. Sovan Satyaprakash, who resigned as Interim CFO to continue as Head of Strategy & Product. The company also proposed appointing MSKA & Associates as Statutory Auditors for three years. These leadership changes aim to strengthen the company's financial governance and strategic oversight.

13:51 IST BSE
Product LaunchRoyal Sense Ltd 544143

Royal Sense Product Launch

Royal Sense Ltd launched 17 new pharmaceutical products, including Vitamin D3 shots, multivitamins, liver tonics, and dermatological creams. Available for sale from April 27, 2026, these products cater to the domestic market. This expansion significantly broadens the company's healthcare portfolio across high-growth nutraceutical and therapeutic segments.